WCU » Kurt A. Wargo

Kurt A. Wargo, PharmD, FCCP, BCPS

Dean & Professor, WCU School of Pharmacy

Biography

Dr. Kurt Wargo is the dean and a professor of the School of Pharmacy at West Coast University, where he brings decades of experience in clinical pharmacy practice and teaching in educational institutions.

Dr. Wargo received his Bachelor of Science in Biology from Kent State University in 1997 and his Doctor in Pharmacy from Creighton University School of Pharmacy in 2002. In 2003, he completed a postdoctoral residency at Memorial Hermann Hospital in Houston, Texas.

Dr. Wargo served on the faculty of Auburn University School of Pharmacy and the University of Alabama-Birmingham, Huntsville School of Medicine from 2003 to 2015. There he practiced pharmacy in internal medicine and infectious diseases.

In 2015, Dr. Wargo became the regional dean of Wingate University in Hendersonville, NC, where he led the school of pharmacy and physician assistant programs. In 2020, he became the dean of the Presbyterian College School of Pharmacy in Clinton, SC.

Dr. Wargo is board-certified in pharmacotherapy, and in 2016, he was elected as a Fellow of the American College of Clinical Pharmacy. He has published over 50 peer-reviewed articles and book chapters during his career.

Publications

Pavuluri N, Aparasu RR, Boje KMK, Danielson J, El-Ibiary SY, Iyer AKV, Ochs LA, Robinson JD, Shah S, Williams CC, Moore TM, Wargo KA. Consideration of Aggressive and Strategic Approaches to Addressing Declining Enrollment in US Pharmacy Schools. Am J Pharm Ed. 2019;83(6): Article 6959.

Sebaaly J, Woods JA, Wargo KA. A Review of Ceftolozane/Tazobactam for the Treatment of Infections Caused by Multidrug-Resistant Pathogens. Infect Dis Clin Pract. 2018;26:198-203.

Owens RE, Wargo KA. Transgender students in pharmacy school, part 2: How faculty advisors can support their advisees. Curr Pharm Teach Learn. 2017;9(6):957-61. https://doi.org/10.1016/j.cptl.2017.07.027

Wargo KA, Owens RE. Transgender students in pharmacy school, part 1: What academic administrators need to know. Curr Pharm Teach Learn. 2017;9(6):951-6. https://doi.org/10.1016/j.cptl.2017.07.007

Wargo KA. Transitioning from Pharmacy Practice into Administration. Curr Pharm Teach Learn. 2017;9(3):344-8. http://dx.doi.org/10.1016/j.cptl.2017.02.006

ACCP Educational Affairs Committee (Schwinghammer TL, Crannage AJ, Boyce EG, Bradley B, Christensen A, Dunnenberger HM, Fravel M, Gurgle H, Hammond DA, Kwon J, Slain D, Wargo KA). The 2016 ACCP Pharmacotherapy Didactic Curriculum Toolkit (ACCP Commentary). Pharmacotherapy. 2016;36(11):e189-94. doi: 10.1002/phar.1846

Mospan GA, Wargo KA. Researchers’ Experience with Clinical Data Sharing. J Am Board Fam Med. 2016;29(6):805-7.

Mospan GA, Wargo KA. Evaluation of an outpatient 5-day course of levofloxacin in males with a urinary tract infection: A subgroup analysis of a previously published trial. J Am Board Fam Med. 2016;29(6):654-62.

Vickery SB, McClain D, Wargo KA. Successful Use of Ceftolozane-Tazobactam to Treat a Pulmonary Exacerbation of Cystic Fibrosis caused by Multidrug-Resistant Pseudomonas aeruginosa. Pharmacotherapy. 2016;36(10):e154–e159 doi: 10.1002/phar.1825

Mospan G, Wargo K. Evaluation of a 5-day course of levofloxacin in males with a urinary tract infection, a subgroup analysis of a previously published trial (Abstract 34). Pharmacotherapy. 2016;36:e83-e138. DOI: 10.1002/phar.1782

Wargo KA, McCreary EK, English TM. Vancomycin combined with clindamycin for the treatment of acute bacterial skin and skin structure infections. Clin Infect Dis. 2015;67:1148-51.

Wargo KA, Edwards JD. Aminoglycoside-Induced Nephrotoxicity. J Pharm Prac. 2014;27:573-77. DOI: 10.1177/0897190014546836

Harris IM, Phillips B, Boyce E, Griesbach S, Hope C, Sanoski C, Sokos D, Wargo K. ACCP White Paper. Clinical Pharmacy Should Adopt a Consistent Process of Direct Patient Care. Pharmacotherapy 2014;34(8):e133–e148.